Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Diagnostic Immunology
|
January 1, 1983
Cell surface phenotype and in vitro function of adult T-cell leukemia cells
T Uchiyama, T Hattori, Y Wano, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1984
Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells
Y Wano, T Uchiyama, K Fukui, et al.
Molecular Biology & Medicine
|
April 1, 1987
Reconstitution of high affinity IL-2 receptor expression in a human T-cell line using a retroviral cDNA expression vector
Y Wano, B R Cullen, P A Svetlik, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society
|
February 1, 1984
Functional analysis of adult T-cell leukemia cells
T Toibana, M Tsudo, Y Wano, et al.
International Journal of Cancer
|
August 15, 1982
Establishment and cytological characteristics of two in vitro T-cell lines derived from a child with acute lymphatic leukemia and a man with adult T-cell leukemia in Japan
M Nagasaka, S Maeda, O Mabuchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1989
[Pharmacokinetics of stearyl-ara-CMP (YNK-01) in patients with hematologic neoplasms]
T Ueda, K Kamiya, T Tanaka, et al.
Leukemia Research
|
January 1, 1990
Successful treatment of myelodysplastic syndrome with 1-beta-D-arabinofuranosylcytosine 5'-stearylphosphate
T Ueda, S Imamura, Y Kawai, et al.
Agents and Actions
|
January 1, 1986
Isolation and characterization of lipocortin (lipomodulin)
F Hirata, Y Notsu, R Yamada, et al.
The Journal of Molecular and Cellular Immunology : JMCI
|
January 1, 1985
Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression
K Teshigawara, M Maeda, K Nishino, et al.
Anticancer Research
|
March 4, 2000
Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation
K Inai, Y Wano, S Yamamoto, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Diagnostic Immunology
|
January 1, 1983
Cell surface phenotype and in vitro function of adult T-cell leukemia cells
T Uchiyama, T Hattori, Y Wano, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1984
Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells
Y Wano, T Uchiyama, K Fukui, et al.
Molecular Biology & Medicine
|
April 1, 1987
Reconstitution of high affinity IL-2 receptor expression in a human T-cell line using a retroviral cDNA expression vector
Y Wano, B R Cullen, P A Svetlik, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society
|
February 1, 1984
Functional analysis of adult T-cell leukemia cells
T Toibana, M Tsudo, Y Wano, et al.
International Journal of Cancer
|
August 15, 1982
Establishment and cytological characteristics of two in vitro T-cell lines derived from a child with acute lymphatic leukemia and a man with adult T-cell leukemia in Japan
M Nagasaka, S Maeda, O Mabuchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1989
[Pharmacokinetics of stearyl-ara-CMP (YNK-01) in patients with hematologic neoplasms]
T Ueda, K Kamiya, T Tanaka, et al.
Leukemia Research
|
January 1, 1990
Successful treatment of myelodysplastic syndrome with 1-beta-D-arabinofuranosylcytosine 5'-stearylphosphate
T Ueda, S Imamura, Y Kawai, et al.
Agents and Actions
|
January 1, 1986
Isolation and characterization of lipocortin (lipomodulin)
F Hirata, Y Notsu, R Yamada, et al.
The Journal of Molecular and Cellular Immunology : JMCI
|
January 1, 1985
Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression
K Teshigawara, M Maeda, K Nishino, et al.
Anticancer Research
|
March 4, 2000
Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation
K Inai, Y Wano, S Yamamoto, et al.
Page
of 5